TASR

TASR Articles

These are some of the top analyst Downgrades and negative calls we are seeing early this Friday morning: Abercrombie & Fitch (ANF) Cut to Neutral at Banc of America. Affymax (AFFY) Cut to Hold at...
Washington Mutual (WM) Concerns about the financial crisis burn like wildfire. Drops sharply to $6.14 from 52-week high of $44.19. AMBAC (ABK) Sells off to $2.02 after downgrades. The 52-week high...
A legal consortium of law firms has just filed suit on behalf of certain shareholders of TASER International Inc. (NASDAQ: TASR).  Two Houston-based firms, The O’Quinn Law Firm and Christian Smith...
Sovereign Bancorp (SOV) Moody’s cuts rating. Drops to $6.48 from 52-week high of $24.71. Select Comfort  (SCSS) Quarter short of expectation. Down to $2.45 from 52-week high of $19.03. Taser...
Below are the top analyst calls that a673b.bigscoots-temp.com is looking at this morning: Capella Education (NASDAQ: CPLA) started as Neutral at JPMorgan. Cephalon (NASDAQ: CEPH) raised to Strong Buy at...
Below is a snapshot of some of the key impact news affecting stocks in pre-market trading this Monday, January 7, 2008: AllianceBernstein (AB) noted as a hidden gem in Barron’s cover story. Answers...
Below is some of the top news pre-market: Applied Materials (AMAT) reports earnings after close; estimates are $0.29 EPS & R$2.38B. BEA Systems (BEAS) said it expects to submit SEC filings...
Merriman upgrades Taser (TASR) from neutral to buy. Lehman (LEH) upgrades Motorola (MOT) from equal weight to overweight. Sun Trust starts Penn Virginia with a buy and $54 price target. Cowen...
TASER International, Inc. (TASR-NASDAQ) has announced a strategic alliance with iRobot Corp. (IRBT-NASDAQ) to develop a new robotic capability utilizing TASER(r) technologies. This combination of...
(AAPL) Apple’s iPhone launches tomorrow.(ABPI) Accentia Biopharma announced favorable interim blinded data on SinuNase in its fast-tracked pivotal Phase III clinical trial.(ALVR) Alvarion in pact...
(ANDW) Andrew Corp being acquired for $15.00 per share.(APOG) Apogee Enterprises $0.34 EPS vs $0.23e; unsure if comparable.(AUTH) AuthenTec priced its 7.5M share IPO at the top of the $9.00 to $11.00...
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
(APPAD) AP Pharmaceuticals announces the pricing of its underwritten public offering of 21.2 million shares of its common stock at a public offering price of $1.65 per share.(BBND) Bigband Networks...